SCHEMBL19081585

SCHEMBL19081585

c1cc(-c2ccc3oc4c(ccc5oc6ccc7ccccc7c6c54)c3c2)cc(-c2c3ccccc3c(-c3ccc4ccccc4c3)c3ccccc23)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 2/20 0.39
CYP1B1 Q16678 1/20 0.39
ABCG2 Q9UNQ0 5/20 0.38
CYP1A2 P05177 2/20 0.38
AHR P35869 2/20 0.38
PAX8 Q06710 2/20 0.38
FYN P06241 1/20 0.38
MAPK3 P27361 1/20 0.38
NPC1 O15118 3/20 0.36
RAB9A P51151 2/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
PLA2G10 O15496 1/20 0.36
PLA2G2A P14555 1/20 0.36
PLA2G4A P47712 1/20 0.36
HSD17B1 P14061 1/20 0.35
HSD17B2 P37059 1/20 0.35
TDP1 Q9NUW8 4/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
KDM4E B2RXH2 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081477 0.94 ABCG2 (0.41) CYP1A1CYP1B1ABCG2CYP1A2AHR
SCHEMBL19081623 0.94 ABCG2 (0.41) CYP1A1CYP1B1ABCG2CYP1A2AHR
SCHEMBL19081513 0.94 ABCG2 (0.41) CYP1A1CYP1B1ABCG2CYP1A2AHR
SCHEMBL19081565 0.94 CYP1A1 (0.40) CYP1A1CYP1B1ABCG2CYP1A2AHR
SCHEMBL19081594 0.93 CYP1A1 (0.39) CYP1A1CYP1B1ABCG2CYP1A2AHR
SCHEMBL19108785 0.92 PLA2G2A (0.38) CYP1A1CYP1B1ABCG2CYP1A2AHR
SCHEMBL17944130 0.92 PLA2G2A (0.39) CYP1A1CYP1B1ABCG2CYP1A2AHR
SCHEMBL17932102 0.92 PLA2G2A (0.39) CYP1A1CYP1B1ABCG2CYP1A2AHR
SCHEMBL19081656 0.91 ALOX5 (0.36) CYP1A1CYP1B1ABCG2CYP1A2AHR
SCHEMBL16067596 0.90 CYP1A1 (0.48) CYP1A1CYP1B1ABCG2CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885ABCG2 4823/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885ABCG2 4823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.